New Diabetes Treatments-Enhanced blood flow

Three diabetes treatments with entirely new modes of action were approved: exenatide injection for people with type 2 diabetes, pramlintide injection as an add-on to insulin therapy for people with type 1 or type 2 diabetes and Sitagliptin also for people with type 2 diabetes. Some diabetes medications help the pancreas release more insulin (if you have type 2 diabetes), others help cells use insulin better, and others keep the liver from releasing too much glucose. The new treatments focus action on hormones called incretins.
Exenatide injection:

  • is injected twice a day at mealtime
  • is for those with type 2 diabetes who have been unable to control blood glucose with oral medicines
  • improves blood glucose control by mimicking incretin hormones, stimulating insulin and slowing stomach-emptying
  • leads to weight loss because patients will feel full faster and stop eating
  • can cause nausea

Exenatide extended release  is  injected once per week is for those with type 2 diabetes who have been unable to control blood glucose with oral medicines  that helps to improves blood glucose control by mimicking incretin hormones, stimulating insulin and slowing stomach-emptying leads to weight loss because patients will feel full faster and stop eating which can cause nausea.

Pramlintide acetate is intended for those with type 1 or type 2 diabetes who use insulin

  • is injected at mealtime
  • is to never mix with insulin in one syringe; which creates the need for an additional injection for the patient
  • used for better glucose control, reduction in blood glucose spikes, reduction in food intake, whichleads to weight loss
  • can cause nausea or hypoglycemia (dangerously low blood glucose)

Sitagliptin Saxagliptin and linagliptin-All three of these pills

  • are taken once a day
  • are for type 2 diabetes
  • do not promote weight gain
  • are often used in combination with metformin
  • have very little, if any, side effects
  • Should be taken with caution for patients with renal disease (dose should be decreased)
  • slows the breakdown of incretins, so insulin is released over a longer period of time

  • Liraglutide Injection
  • Exenatide Injection
  • Exenatide extended release Injection
  • Pramlintide acetate(Mealtime Injection)
  • Sitagliptin and Metformin (Dipeptidyl Peptidase-4 Inhibitors)
  • Saxagliptin and Metformin
  • Linagliptin and Metformin

Related Conference of New Diabetes Treatments-Enhanced blood flow

May 17-18, 2019

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Singapore Atrium | Singapore
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
July 29-30, 2019

21st Asia Pacific Diabetes Conference

Sydney, Australia
June 27-28, 2019 |

18th Global Conference on Diabetes and Nursing Care

Amsterdam, Netherlands
July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
September 18-19, 2019

12th International Conference on Diabetes & Metabolism

San Francisco | California | USA
September 21-22, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
September 21-22, 2019

Euro Diabetes Congress & Expo

Prague, Czech Republic
October 14-15, 2019

Global congress on Endocrinology and Gynecology

Sydney, Australia
October 23-24, 2019

Annual Summit on Metabolomics

Amsterdam, Netherlands
November 25-26, 2019

Global Summit On Diabetes & Endocrinology

Yokohama, Japan
December 02-03, 2019 |

14th European Diabetes and Endocrinology Congress

Barcelona, Spain
December 04-05, 2019

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan

New Diabetes Treatments-Enhanced blood flow Conference Speakers

Recommended Sessions

Related Journals

Are you interested in